NASDAQ:SIEN - Sientra Stock Price, Forecast & News

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra Inc (NASDAQ:SIEN) released its quarterly earnings results on Thursday, November, 7th. The medical instruments supplier reported ($0.45) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.47) by $0.02. The medical instruments supplier earned $22.41 million during the quarter, compared to the consensus estimate of $20.05 million. Sientra had a negative return on equity of 122.95% and a negative net margin of 143.76%. The business's quarterly revenue was up 32.8% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.72) EPS. View Sientra's Earnings History.

Sientra is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Sientra.

Sientra updated its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $23.2-23.2 million, compared to the consensus revenue estimate of $22.74 million.

8 brokerages have issued 1-year price targets for Sientra's stock. Their forecasts range from $10.00 to $27.00. On average, they expect Sientra's stock price to reach $15.75 in the next year. This suggests a possible upside of 165.6% from the stock's current price. View Analyst Price Targets for Sientra.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.

News headlines about SIEN stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sientra earned a media sentiment score of 1.3 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Sientra.

Some companies that are related to Sientra include Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Bionik Laboratories (BNKL), NanoVibronix (NAOV), Precision Therapeutics (POAI), Ocugen (OCGN), Allied Healthcare Products (AHPI), Rewalk Robotics (RWLK) and Avitar (AVTI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Genocea Biosciences (GNCA), Verizon Communications (VZ), Novavax (NVAX), Rigel Pharmaceuticals (RIGL), Regions Financial (RF), Baidu (BIDU), ChemoCentryx (CCXI), Idera Pharmaceuticals (IDRA), Opko Health (OPK) and AbbVie (ABBV).

Sientra's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include UBS Group AG (4.84%), Schroder Investment Management Group (3.78%), Bamco Inc. NY (2.84%), Goldman Sachs Group Inc. (2.61%), Broadfin Capital LLC (2.60%) and UBS Asset Management Americas Inc. (2.16%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

SIEN stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, J. Goldman & Co LP, UBS Group AG, Barclays PLC, Bamco Inc. NY, Schroder Investment Management Group, Millrace Asset Group Inc. and Private Advisor Group LLC. View Insider Buying and Selling for Sientra.

SIEN stock was bought by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, EAM Investors LLC, Assenagon Asset Management S.A., EAM Global Investors LLC, State Street Corp, Marshall Wace North America L.P., Granite Point Capital Management L.P. and Bank of New York Mellon Corp. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $5.93.

Sientra has a market capitalization of $293.42 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.View Additional Information About Sientra.

The official website for Sientra is http://www.sientra.com/.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]